ERS Research Seminars
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Key challenges faced for approval of anti-inflammatory drugs for asthma and COPD - European Medicines Agency perspective
Laura Fregonese (London, United Kingdom)
Research Seminar 2022 – Pharmacology of asthma and COPD: current and future developments
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laura Fregonese (London, United Kingdom). Key challenges faced for approval of anti-inflammatory drugs for asthma and COPD - European Medicines Agency perspective. Research Seminar 2022 – Pharmacology of asthma and COPD: current and future developments
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery